| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nurix Therapeutics, Inc. (NRIX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. NRIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 50.0K | $932.5K | - | |
| CFO | 47.4K | $884.5K | - | |
| Dir | 22.6K | $421.2K | - | |
| Other | 15.0K | $279.8K | - | |
| Other | 13.6K | $253.2K | -8,148 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 400 | $32.34 | $12,936.00 | -2.7% | -9.8% | -48.7% | |
| Aug 10, 2021 | Ring Christine77 | General Counsel | Sale+OE | 1,200 | $29.87 | $35,844.96 | -59.9% | +10.2% | -34.7% | |
| Aug 10, 2021 | Beaurang Pierre64 | Chief Business Officer | Sale+OE | 7,500 | $29.86 | $223,925.93 | -41.6% | +10.2% | -34.7% | |
| Aug 2, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 400 | $31.21 | $12,484.00 | -2.8% | +8.1% | -48.1% | |
| Jul 20, 2021 | Ring Christine77 | General Counsel | Sale+OE | 1,200 | $27.00 | $32,400.00 | -59.9% | -1.2% | -40.9% | |
| Jul 12, 2021 | Beaurang Pierre64 | Chief Business Officer | Sale+OE | 7,500 | $23.92 | $179,418.70 | -45.3% | +17.2% | -33.2% | |
| Jul 1, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 400 | $26.76 | $10,704.00 | -2.8% | +6.8% | -51.7% | |
| Jun 10, 2021 | Ring Christine77 | General Counsel | Sale+OE | 1,200 | $29.40 | $35,282.00 | -39.9% | +20.6% | -65.4% | |
| Jun 10, 2021 | Beaurang Pierre64 | Chief Business Officer | Sale+OE | 7,500 | $29.37 | $220,248.49 | -33.5% | +20.6% | -65.4% | |
| Jun 1, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 400 | $27.74 | $11,096.00 | -2.8% | +16.9% | -66.6% |